Development of an Artificial Cell, from Self- INAUGURAL ARTICLE Organization to Computation and Self-Reproduction
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Global Transposon Mutagenesis and a Minimal Mycoplasma Genome
R EPORTS thermore, while immunosubunit precursors- stained positive, whereas no staining of PA28Ϫ/Ϫ purchased from PharMingen (San Diego, CA). 25D1.16 containing 15S proteasome assembly inter- cells was observed. (10) and a PA28a-specific antiserum (2) were kindly 11. S. C. Jameson, F. R. Carbone, M. J. Bevan, J. Exp. Med. provided by A. Porgador and M. Rechsteiner, respective- mediates were detected in wild-type cells, 177, 1541 (1993). ly. Metabolic labeling, immunoprecipitation, immuno- under identical conditions 15S complexes 12. T. Preckel and Y. Yang, unpublished results. blotting, and sodium dodecyl sulfateÐpolyacrylamide were hardly detectable in PA28Ϫ/Ϫ cells (Fig. 13. M. Ho, Cytomegalovirus: Biology and Infection (Ple- gel electrophoresis (SDS-PAGE) were performed as de- 4B). Notably, PA28 was found to be associ- num, New York, ed. 2, 1991). scribed (3). 14. P. Borrow and M. B. A. Oldstone, in Viral Pathogenesis, 19. T. Flad et al., Cancer Res. 58, 5803 (1998). ated with the immunosubunit precursor-con- N. Nathanson, Ed. (Lippincott-Raven, Philadelphia, 20. M. W. Moore, F. R. Carbone, M. J. Bevan, Cell 54, 777 taining 15S complexes, suggesting that PA28 1997), pp. 593Ð627; M. J. Buchmeier and A. J. Zajac, (1988). is required for the incorporation of immuno- in Persistent Virus Infections, R. Ahmed and I. Chen, 21. A. Vitiello et al., Eur. J. Immunol. 27, 671 (1997). Eds. ( Wiley, New York, 1999), pp. 575Ð605. subunits into proteasomes. 22. H. Bluthmann et al., Nature 334, 156 (1988). 15. G. Niedermann et al., J. Exp. Med. 186, 209 (1997); 23. W. Jacoby, P. V. Cammarata, S. -
Droplet Microfluidics for Tumor Drug‐Related Studies And
REVIEW www.global-challenges.com Droplet Microfluidics for Tumor Drug-Related Studies and Programmable Artificial Cells Pantelitsa Dimitriou,* Jin Li, Giusy Tornillo, Thomas McCloy, and David Barrow* robotics, have promoted the use of in vitro Anticancer drug development is a crucial step toward cancer treatment, tumor models in high-throughput drug that requires realistic predictions of malignant tissue development and screenings.[2,3] High-throughput screens sophisticated drug delivery. Tumors often acquire drug resistance and drug for anticancer drugs have been, for a long efficacy, hence cannot be accurately predicted in 2D tumor cell cultures. time, limited to 2D culture of tumor cells, grown as a monolayer on the bottom of On the other hand, 3D cultures, including multicellular tumor spheroids a well of a microtiter plate. Compared to (MCTSs), mimic the in vivo cellular arrangement and provide robust 2D cell cultures, 3D culture systems can platforms for drug testing when grown in hydrogels with characteristics more faithfully model cell-cell interactions, similar to the living body. Microparticles and liposomes are considered smart matrix deposition and tumor microenvi- drug delivery vehicles, are able to target cancerous tissue, and can release ronments, including more physiological flow conditions, oxygen and nutrient gra- entrapped drugs on demand. Microfluidics serve as a high-throughput dients.[4] Therefore, 3D cultures have tool for reproducible, flexible, and automated production of droplet-based recently begun to be incorporated into microscale constructs, tailored to the desired final application. In this high-throughput drug screenings, with the review, it is described how natural hydrogels in combination with droplet aim of better predicting drug efficacy and microfluidics can generate MCTSs, and the use of microfluidics to produce improving the prioritization of candidate tumor targeting microparticles and liposomes. -
Development of Artificial Cell Culture Platforms Using Microfluidics
DEVELOPMENT OF ARTIFICIAL CELL CULTURE PLATFORMS USING MICROFLUIDICS By HANDE KARAMAHMUTOĞLU Submitted to the Graduate School of Engineering and Natural Sciences in partial fulfillment of the requirements for the degree of Master of Science Sabanci University July 2019 DEVELOPMENT OF ARTIFICIAL CELL CULTURE PLATFORMS USING MICROFLUIDICS APPROVED BY Assoc. Prof. Dr. Meltem Elita¸s .............................................. (Thesis Supervisor) Assist. Prof. Dr. Murat Kaya Yapıcı .............................................. Assoc. Prof. Dr. Ali Özhan Aytekin .............................................. DATE OF APPROVAL: .............................................. ii © Hande Karamahmutoğlu 2019 All Rights Reserved iii ABSTRACT DEVELOPMENT OF ARTIFICIAL CELL CULTURE PLATFORMS USING MICROFLUIDICS HANDE KARAMAHMUTOGLU Mechatronics Engineering, MSc, Thesis, July 2019 Thesis Supervisor: Assoc. Prof. Dr. Meltem Elitas Key Words: Cell Culture, Cancer, Microfluidics, Lab-on-a-chip and Single-cell resolution. Acquiring quantitative data about cells, cell-cell interactions and cellular responses to surrounding environments are crucial for medical diagnostics, treatment and cell biology research. Nowadays, this is possible through microfluidic cell culture platforms. These devices, lab-on-a-chip (LOC), are capable of culturing cells with the feature of mimicking in vivo cellular conditions. Through the control of fluids in small volumes, LOC closely mimics the nature of cells in the tissues compared to conventional cell culturing platforms -
Commentary the Minimal Cell Genome: ''On Being the Right Size”
Proc. Natl. Acad. Sci. USA Vol. 93, pp. 10004–10006, September 1996 Commentary The minimal cell genome: ‘‘On being the right size” Jack Maniloff* Department of Microbiology and Immunology, University of Rochester, Medical Center Box 672, Rochester, NY 14642 ‘‘On being the right size’’ is in quotation marks in the title these studies, it is important to remember that organisms with because it has been used twice before–in each case to discuss small genomes have arisen by two vastly different evolutionary the size of biological systems in terms of interest at that time. pathways, one ‘‘top down’’ and the other ‘‘bottom up.’’ J. B. S. Haldane (1) originally used this title in the 1920s, for ‘‘Top down’’ genomes evolved in organisms with increasing a paper describing the relationship between animal size and metabolic requirements. At each metabolic level, there can be constraints like gravity, surface tension, and food and oxygen a minimal genome: from photoautotrophs, able to grow in a consumption. In the 1970s, N. W. Pirie (2) (acknowledging medium of only CO2, light, and inorganic salts; to simple Haldane) used the title for a paper analyzing how factors like heterotrophs, for which growth requires a basic medium membrane properties, water structure, and the volume needed containing an organic carbon and energy source (like glucose) for ribosomes and other macromolecules set lower limits on and inorganic salts; to fastidious heterotrophs, for which cell size. Now, in the 1990s, the title is used to discuss efforts growth requires a complex medium, frequently containing to define the minimal genome content necessary and sufficient undefined components (like serum); to obligate intracellular for a living cell. -
Synthetic Biology As a Technoscience: the Case of Minimal Genomes and Essential Genes
Published in Studies in History and Philosophy of Science (epub ahead of print) Synthetic Biology as a Technoscience: The Case of Minimal Genomes and Essential Genes Massimiliano Simons, Ghent University [email protected] Department of Philosophy and Moral Sciences, Blandijnberg 2, BE-9000, Ghent Abstract This article examines how minimal genome research mobilizes philosophical concepts such as minimality and essentiality. Following a historical approach the article aims to uncover what function this terminology plays and which problems are raised by them. Specifically, four historical moments are examined, linked to the work of Harold Morowitz, Mitsuhiro Itaya, Eugene Koonin and Arcady Mushegian, and J. Craig Venter. What this survey shows is a historical shift away from historical questions about life or descriptive questions about specific organisms towards questions that explore biological possibilities: what are possible forms of minimal genomes, regardless of whether they exist(ed) in nature? Moreover, it highlights a fundamental ambiguity at work in minimal genome research between a universality claim and a standardization claim: does a minimal genome refer to the minimal gene set for any organism whatsoever? Or does it refer rather to a gene set that will provide stable, robust and predictable behaviour, suited for biotechnological applications? Two diagnoses are proposed for this ambiguity: a philosophical diagnosis of how minimal genome research either misunderstands the ontology of biological entities or philosophically misarticulates scientific practice. Secondly, a historical diagnosis that suggests that this ambiguity is part of a broader shift towards technoscience. Keywords: Minimal genome ; essential gene; Mycoplasma ; Craig Venter; synthetic biology ; technoscience Competing interests No competing interests to declare. -
In Vivo and in Silico Metabolic and Genome Engineering
Landon, S. , Rees, J., Marucci, L., & Grierson, C. (2019). Genome- driven cell engineering review: In vivo and in silico metabolic and genome engineering. Essays in Biochemistry, 63(2), 267-284. https://doi.org/10.1042/EBC20180045 Publisher's PDF, also known as Version of record License (if available): CC BY Link to published version (if available): 10.1042/EBC20180045 Link to publication record in Explore Bristol Research PDF-document University of Bristol - Explore Bristol Research General rights This document is made available in accordance with publisher policies. Please cite only the published version using the reference above. Full terms of use are available: http://www.bristol.ac.uk/red/research-policy/pure/user-guides/ebr-terms/ Essays in Biochemistry (2019) 63 267–284 https://doi.org/10.1042/EBC20180045 Review Article Genome-driven cell engineering review: in vivo and in silico metabolic and genome engineering Sophie Landon1,2,*, Joshua Rees-Garbutt1,3,*, Lucia Marucci1,2,4,† and Claire Grierson1,3,† 1BrisSynBio, University of Bristol, Bristol BS8 1TQ, U.K.; 2Department of Engineering Mathematics, University of Bristol, Bristol BS8 1UB, U.K.; 3School of Biological Sciences, University of Bristol, Life Sciences Building, Bristol BS8 1TQ, U.K.; 4School of Cellular and Molecular Medicine, University of Bristol, Bristol BS8 1UB, U.K. Correspondence: Claire Grierson ([email protected]) or Lucia Marucci ([email protected]) Producing ‘designer cells’ with specific functions is potentially feasible in the near future. Re- cent developments, including whole-cell models, genome design algorithms and gene edit- ing tools, have advanced the possibility of combining biological research and mathematical modelling to further understand and better design cellular processes. -
Darwinian Evolution in a Translation-Coupled RNA Replication System Within a Cell-Like Compartment
ARTICLE Received 28 Mar 2013 | Accepted 22 Aug 2013 | Published 3 Oct 2013 DOI: 10.1038/ncomms3494 Darwinian evolution in a translation-coupled RNA replication system within a cell-like compartment Norikazu Ichihashi1,2, Kimihito Usui1, Yasuaki Kazuta1, Takeshi Sunami1,2, Tomoaki Matsuura1,2,3 & Tetsuya Yomo1,2,4 The ability to evolve is a key characteristic that distinguishes living things from non-living chemical compounds. The construction of an evolvable cell-like system entirely from non-living molecules has been a major challenge. Here we construct an evolvable artificial cell model from an assembly of biochemical molecules. The artificial cell model contains artificial genomic RNA that replicates through the translation of its encoded RNA replicase. We perform a long-term (600-generation) replication experiment using this system, in which mutations are spontaneously introduced into the RNA by replication error, and highly replicable mutants dominate the population according to Darwinian principles. During evolution, the genomic RNA gradually reinforces its interaction with the translated replicase, thereby acquiring competitiveness against selfish (parasitic) RNAs. This study provides the first experimental evidence that replicating systems can be developed through Darwinian evolution in a cell-like compartment, even in the presence of parasitic replicators. 1 Exploratory Research for Advanced Technology, Japan Science and Technology Agency, Osaka University, Suita, Osaka 565-0871, Japan. 2 Graduate School of Information Science and Technology, Osaka University, Suita, Osaka 565-0871, Japan. 3 Graduate School of Engineering, Osaka University, Suita, Osaka 565-0871, Japan. 4 Graduate School of Frontier Biosciences, Osaka University, Suita, Osaka 565-0871, Japan. Correspondence and requests for materials should be addressed to T.Y. -
Self-Replication of DNA by Its Encoded Proteins in Liposome-Based Synthetic Cells
ARTICLE DOI: 10.1038/s41467-018-03926-1 OPEN Self-replication of DNA by its encoded proteins in liposome-based synthetic cells Pauline van Nies1, Ilja Westerlaken1, Duco Blanken1, Margarita Salas2, Mario Mencía2 & Christophe Danelon1 Replication of DNA-encoded information and its conversion into functional proteins are universal properties of life. In an effort toward the construction of a synthetic minimal cell, we implement here the DNA replication machinery of the Φ29 virus in a cell-free gene fi 1234567890():,; expression system. Ampli cation of a linear DNA template by self-encoded, de novo syn- thesized Φ29 proteins is demonstrated. Complete information transfer is confirmed as the copied DNA can serve as a functional template for gene expression, which can be seen as an autocatalytic DNA replication cycle. These results show how the central dogma of molecular biology can be reconstituted and form a cycle in vitro. Finally, coupled DNA replication and gene expression is compartmentalized inside phospholipid vesicles providing the chassis for evolving functions in a prospective synthetic cell relying on the extant biology. 1 Department of Bionanoscience, Kavli Institute of Nanoscience, Delft University of Technology, van der Maasweg 9, Delft 2629 HZ, The Netherlands. 2 Centro de Biología Molecular “Severo Ochoa” (CSIC-UAM), Universidad Autónoma, Canto Blanco, Madrid 28049, Spain. Correspondence and requests for materials should be addressed to C.D. (email: [email protected]) NATURE COMMUNICATIONS | (2018) 9:1583 | DOI: 10.1038/s41467-018-03926-1 | www.nature.com/naturecommunications 1 ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/s41467-018-03926-1 he in vitro construction of a minimal cell from separate necessary to regenerate the parental DNA. -
REVIEW Viral Vectors for Gene Delivery and Gene Therapy Within the Endocrine System
103 REVIEW Viral vectors for gene delivery and gene therapy within the endocrine system D Stone, A David, F Bolognani, P R Lowenstein and M G Castro Molecular Medicine and Gene Therapy Unit, Room 1.302, Stopford Building, School of Medicine, University of Manchester, Oxford Road, Manchester M13 9PT, UK (Requests for offprints should be addressed to M G Castro; Email: [email protected]) (F Bolognani is now at INIBIOLP-Histology B, Faculty of Medicine, National University of La Plata, Argentina) Abstract The transfer of genetic material into endocrine cells and use in gene transfer and gene therapy applications. As differ- tissues, both in vitro and in vivo, has been identified as critical ent viral vector systems have their own unique advantages for the study of endocrine mechanisms and the future treat- and disadvantages, they each have applications for which ment of endocrine disorders. Classical methods of gene they are best suited. This review will discuss viral vector transfer, such as transfection, are inefficient and limited systems that have been used for gene transfer into the mainly to delivery into actively proliferating cells in vitro. endocrine system, and recent developments in viral vector The development of viral vector gene delivery systems is technology that may improve their use for endocrine beginning to circumvent these initial setbacks. Several kinds applications – chimeric vectors, viral vector targeting and of viruses, including retrovirus, adenovirus, adeno-associated transcriptional regulation of transgene expression. virus, and herpes simplex virus, have been manipulated for Journal of Endocrinology (2000) 164, 103–118 Introduction ing of transgenes within mammalian cells is an area of rapid development. -
Designing Minimal Genomes Using Whole-Cell Models
ARTICLE https://doi.org/10.1038/s41467-020-14545-0 OPEN Designing minimal genomes using whole-cell models ✉ Joshua Rees-Garbutt1,2,7, Oliver Chalkley1,3,4,7, Sophie Landon1,3, Oliver Purcell5, Lucia Marucci1,3,6,8 & ✉ Claire Grierson1,2,8 In the future, entire genomes tailored to specific functions and environments could be designed using computational tools. However, computational tools for genome design are 1234567890():,; currently scarce. Here we present algorithms that enable the use of design-simulate-test cycles for genome design, using genome minimisation as a proof-of-concept. Minimal gen- omes are ideal for this purpose as they have a simple functional assay whether the cell replicates or not. We used the first (and currently only published) whole-cell model for the bacterium Mycoplasma genitalium. Our computational design-simulate-test cycles discovered novel in silico minimal genomes which, if biologically correct, predict in vivo genomes smaller than JCVI-Syn3.0; a bacterium with, currently, the smallest genome that can be grown in pure culture. In the process, we identified 10 low essential genes and produced evidence for at least two Mycoplasma genitalium in silico minimal genomes. This work brings combined computational and laboratory genome engineering a step closer. 1 BrisSynBio, University of Bristol, Bristol BS8 1TQ, UK. 2 School of Biological Sciences, University of Bristol, Bristol Life Sciences Building, 24 Tyndall Avenue, Bristol BS8 1TQ, UK. 3 Department of Engineering Mathematics, University of Bristol, Bristol BS8 1UB, UK. 4 Bristol Centre for Complexity Science, Department of Engineering Mathematics, University of Bristol, Bristol BS8 1UB, UK. -
Grundlagen Mikro- Und Nanosysteme
GrundlagenGrundlagen Mikro-Mikro- undund NanosystemeNanosysteme Mikro- und Nanosysteme in der Umwelt, Biologie und Medizin Synthetische Biologie Dr. Marc R. Dusseiller Mikrosysteme – FS10 Slide 1 SynthetischeSynthetische BiologieBiologie Was ist Synthetische Biologie BioBricks Minimales Genome Mycoplasma Genitalium Mycolplasma mycoides JCVI-syn1.0 Mikrosysteme – FS10 Slide 2 WasWas istist SynthetischeSynthetische BiologieBiologie http://openwetware.org http://www.biobricks.org http://syntheticbiology.org/ Mikrosysteme – FS10 Slide 3 “What I cannot build, I cannot understand.” “What I cannot create, I do not understand.” Richard Feynman, on his blackboard, 1988 American physicist, 1918 - 1988 Mikrosysteme – FS10 Slide 4 MinimalMinimal GenomeGenome ProjectProject “What I cannot build, I cannot understand.” Richard Feynman Kingdom: Bacteria, Class: Mollicutes, Genus: Mycoplasma absence of cell wall, soft, typically 0.2-0.3 μm in size, very small genome size. Mycoplasma genitalium | natural 482 genes comprising 580,000 bp, arranged on one circular chromosome. Mycoplasma laboratorium | 2003 minimal set of 382 genes that can sustain life. → lots of patents already on it by JCVI Mycoplasma genitalium JCVI-1.0 | 2008 Synthetic Genome copy of M. genitalium, including some modifications for safety and “watermarks” → not successfully transplanted Mycoplasma mycoides | natural 1,000,000 pb genome, parasite that lives in ruminants (cattle and goats), causing lung disease. Mycoplasma capricolum | natural recipient host cell pathogen of goats, but has also been found in sheep and cows. Mikrosysteme – FS10 Slide 5 SynthetischeSynthetische OrganismenOrganismen Mycolplasma mycoides JCVI-syn1.0 Publiziert am 20. Mai 2010 E. Pennisi Science 328, 958-959 (2010) http://www.sciencemag.org/cgi/content/abstract/science.1190719 Mikrosysteme – FS10 Slide 6 MycolplasmaMycolplasma mycoidesmycoides JCVI-syn1.0JCVI-syn1.0 From C. -
Methane Emissions Associated with Natural Gas Production in the United States
E E OCTOBER 29, 2013 HIS ISSU T HIS ISSU T IN IN THIS ISSUE IN In This Issue Methane emissions associated with copied their RNA via spontaneous reactions, Shenglong Zhang et al. (pp. 17732–17737) studied a close chemical relative of RNA known natural gas production in the as 3'-phosphoramidate-DNA to uncover the mechanisms of non- United States enzymatic replication. The authors found that although short re- gions of this polymer can be copied, the error rate is prohibitively Significant uncertainty surrounds the levels of methane emissions high. However, the authors found that replacing a single atom in associated with natural gas production in the United States. National one of the four nucleotides both increases the molecule’s poly- estimates of methane emissions from natural gas production have merization rate and restores the copying accuracy. The findings may generally relied on engineering models and measurements made up help develop techniques to chemically copy RNA and suggest that to 1 km downwind of the drill site. In conjunction with an envi- 3'-phosphoramidate-DNA can potentially serve as a genetic material ronmental group and nine natural gas companies, David Allen et for artificial biological systems, according to the authors. — T.J. al. (pp. 17768–17773) directly measured methane emissions at 190 onshore natural gas production sites throughout the United States, including 27 wells being prepared for continuous production and Adaptive benefits of suicidal reproduction 489 wells that underwent hydraulic fracturing. The authors found A radical reproductive strategy called semelparity, in which males that the emissions measured at wells during completion varied over die after mating following a rise in stress hormone levels during the a large range but were, on average, nearly 50 times lower than previ- mating season and immune system collapse, is common among four ously estimated by the Environmental Protection Agency (EPA).